Showing results (391-400 of 465) with videos related to

Sort By:
Pageof 47
Physical Review Letters|December 10, 2013
Kinks in the σ band of graphene induced by electron-phonon couplingFederico Mazzola, Justin W Wells, Rositza Yakimova, et al.
Physical Chemistry Chemical Physics : PCCP|September 4, 2023
Mono-phosphorylation at Ser4 of barrier-to-autointegration factor (Banf1) significantly reduces its DNA binding capability by inducing critical changes in its local conformation and DNA binding surfaceMing Tang, Amila Suraweera, Xuqiang Nie, et al.
Parasitology|November 20, 1998
Cloning and characterization of a 150 kDa microsphere antigen of Theileria parva that is immunologically cross-reactive with the polymorphic immunodominant molecule (PIM)R A Skilton, R P Bishop, C W Wells, et al.
Radiology|January 1, 1997
Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly--data from the Cardiovascular Health StudyR N Bryan, S W Wells, T J Miller, et al.
Hybridoma|January 1, 1984
Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopesC B Reimer, D J Phillips, C H Aloisio, et al.
Plastic and Reconstructive Surgery|June 19, 2023
Same-Day Discharge for Immediate Breast Reconstruction: A National Surgical Quality Improvement Program StudyAmanda Miller, Nirbhay S Jain, Michael W Wells, et al.
Transfusion Medicine (Oxford, England)|September 9, 2009
The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood ServiceA W Wells, C A Llewelyn, A Casbard, et al.
Immunology and Cell Biology|January 21, 2015
HPV16 E7 expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesionsAnne-Sophie Bergot, Nastasia Monnet, Son Le Tran, et al.
Multiple Sclerosis and Related Disorders|May 27, 2015
Risk tolerance to MS therapies: Survey results from the NARCOMS registryRobert J Fox, Amber Salter, Joan M Alster, et al.
Journal of Hematotherapy|October 1, 1995
Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neuF H Valone, P A Kaufman, P M Guyre, et al.
Pageof 47